Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry-Reference-Cited by-同舟云学术

Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry

Published:2022-08 Issue: Volume:41 Page:69-75
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Galli Stefano,Troiano Sarah,Palloshi Altin,Rapetto Claudio,Pisano Francesco,Aprigliano Gianfranco,Leoncini Massimo,Ravagnani Paolo,Del Maestro Martina,Montorsi Piero

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference26 articles.

1. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials;Cassese;Lancet,2016

2. Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents;Sorrentino;J Am Coll Cardiol,2017

3. Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: a meta-analysis of randomized controlled trials;Montone;Circulation,2017

4. Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: magmaris versus absorb in a porcine arteriovenous shunt model;Waksman;Circ Cardiovasc Interv,2017

5. Developments in metallic biodegradable stents;Hermawan;Acta Biomater,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Pre-dilatation Treatment before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis. The OPTIMIS trial;2024-07-29

2. Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years);Advances in Interventional Cardiology;2024

3. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry;Cardiovascular Revascularization Medicine;2023-12

4. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study;EuroIntervention;2023-08

5. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease the prospective, international, multicentre BIOSOLVE-IV registry;EUROINTERVENTION;2023